Dr Martens Plc (DOCMF) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to Dr. Martin's FY25 Q3 trading update. I will now hand over to Chief Executive Officer E.J. Macquarie. Please go ahead. Good morning, everyone. Thank you for joining today's call. I'm joined in the room by Giles Wilson, our CFO, and Bethany Barnes, who heads up IR here. Hopefully you've seen this morning's Q3 trading statement. Q3 trading was as expected and our guidance is unchanged. I'll give some detail on how we're feeling about trading that in a moment, and then we'll open it up for your questions. Before I do, though, I want to say how excited I am to have taken on the role as CEO of Dr. Martin's. I also want to take a moment to thank Kenny, my predecessor. He was a great leader of this business for seven years, and I'm truly grateful for the time and commitment he put into a thorough and smooth transition. I spoke at the half-year results about what makes Dr. Martin's such a strong brand. its resonance across demographics and cultures, consumer recognition of our premium quality design and craft, and our product attributes, comfort, style, protection, things that are sought after by consumers everywhere. My job as CEO is to capitalize on these qualities, make Docs an even more effective organization, and pursue the growth opportunities this brand presents. Right now, that means delivering FY25 on the four objectives we set out to achieve. Right-sizing our operating cost base, strengthening our balance sheet, pivoting our marketing to relentlessly focus on our product, and returning our USA DDC business to growth in the second half. We talked at length during the first, about the first three of these objectives at the first half results, and we're well on track with all of them. It was too soon then to talk about USA DTC performance. H...